Patents by Inventor Christiane Fuerst

Christiane Fuerst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Long-Acting Formulations of Insulin
    Publication number: 20210308225
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: February 16, 2021
    Publication date: October 7, 2021
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Long-Acting Formulations of Insulin
    Publication number: 20200384087
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: May 13, 2020
    Publication date: December 10, 2020
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Long-Acting Formulations of Insulin
    Publication number: 20200215163
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: September 17, 2019
    Publication date: July 9, 2020
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Long-Acting Formulations of Insulin
    Publication number: 20190388511
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: March 28, 2019
    Publication date: December 26, 2019
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Long-Acting Formulations of Insulin
    Publication number: 20190046616
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: August 21, 2018
    Publication date: February 14, 2019
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Long-Acting Formulations of Insulin
    Publication number: 20160339084
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: May 23, 2016
    Publication date: November 24, 2016
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Long-Acting Formulations of Insulin
    Publication number: 20160228516
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: April 20, 2016
    Publication date: August 11, 2016
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Long-acting formulations of insulin
    Patent number: 9345750
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Grant
    Filed: March 20, 2014
    Date of Patent: May 24, 2016
    Assignee: SANOFI
    Inventors: Reinhard Becker, Annke Hahn, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • Long-Acting Formulations of Insulin
    Publication number: 20150164999
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: February 17, 2015
    Publication date: June 18, 2015
    Inventors: Reinhard Becker, Annke Frick, Peter Boderke, Christiane Fuerst, Werner Mueller, Ulrich Werner
  • LONG-ACTING INSULIN FORMULATIONS
    Publication number: 20140206611
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: March 20, 2014
    Publication date: July 24, 2014
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Frick, Peter Boderke, Christiane Fuerst, Werner Mueller, Katrin Teresch, Ulrich Werner, Petra Loos, Isabell Schoettle
  • INSULIN PREPARATIONS CONTAINING METHIONINE
    Publication number: 20120252724
    Abstract: The invention relates to an aqueous pharmaceutical formulation having insulin, an insulin analog, or an insulin derivative, and methionine; and to the production thereof, to the use thereof for treating diabetes mellitus, and to a medication for treating diabetes mellitus.
    Type: Application
    Filed: July 2, 2010
    Publication date: October 4, 2012
    Applicant: SANOFI-AVENTIS
    Inventors: Isabell Schoettle, Annika Hagendorf, Christiane Fuerst, Gerrit Hauck, Verena Siefke-Henzler, Walter Kamm, Julia Schnieders
  • HEAT- AND VIBRATION-STABLE INSULIN PREPARATIONS
    Publication number: 20120241356
    Abstract: The invention relates to a method for producing an aqueous, pharmaceutical formulation comprising an insulin, an insulin analog, or an insulin derivative, wherein the ready-made formulation takes place directly by dissolving the insulin, the insulin analog, or the insulin derivative as a solid in a suitable solvent mixture.
    Type: Application
    Filed: July 2, 2010
    Publication date: September 27, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Anja Pfenninger, Norbert Tennagels, Christiane Fuerst
  • SLOW-ACTING INSULIN PREPARATIONS
    Publication number: 20120232002
    Abstract: Aqueous pharmaceutical formulations with an insulin analog, comprising 0.001 to 0.2 mg/ml of zinc, 0.1 to 5.0 mg/ml of a preservative, and 5.0 to 100 mg/ml of an isotonicity agent, and whose pH is 5 or less, and also their preparation, use for treating diabetes mellitus, and a medicament for treating diabetes mellitus.
    Type: Application
    Filed: July 2, 2010
    Publication date: September 13, 2012
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Isabell Schoettle, Christiane Fuerst, Verena Siefke-Henzler, Gerrit Hauck, Walter Kamm, Julia Schnieders, Jutta Carls, Gert Wolf
  • LONG-ACTING FORMULATIONS OF INSULINS
    Publication number: 20120122774
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: December 2, 2011
    Publication date: May 17, 2012
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Frick, Peter Boderke, Christiane Fürst, Werner Müller, Katrin Tertsch, Ulrich Werner, Petra Loos, Isabell Schöttle
  • LONG-ACTING FORMULATIONS OF INSULINS
    Publication number: 20110301081
    Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
    Type: Application
    Filed: May 18, 2011
    Publication date: December 8, 2011
    Applicant: SANOFI
    Inventors: Reinhard Becker, Annke Frick, Peter Boderke, Christiane Fürst, Werner Müller, Katrin Tertsch, Ulrich Werner, Petra Loos, Isabell Schöttle